PRELIMINARY COST-EFFECTIVENESS ANALYSIS OF PROTON BEAM THERAPY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA IN JAPAN

被引：0
|
作者：
Moriwaki, K. [1 ]
Katoh, N. [2 ]
Hayashi, H. [2 ]
Miyakoshi, T. [2 ]
Terashima, K. [3 ]
Murayama, S. [4 ]
Suzuki, M. [5 ]
Okumura, T. [6 ]
Araya, M. [7 ]
Hojo, H. [8 ]
Iwata, H. [9 ]
机构：
[1] Ritsumeikan Univ, Kyoto 26, Japan
[2] Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan
[3] Hyogo Ion Beam Med Ctr, Tatsuno, Hyogo, Japan
[4] Shizuoka Canc Ctr, Shizuoka, Japan
[5] Southern Tohoku Proton Therapy Ctr, Fukushima, Japan
[6] Univ Tsukuba, Ibaraki, Japan
[7] Aizawa Hosp, Nagano, Japan
[8] Natl Canc Ctr Hosp East, Chiba, Japan
[9] Nagoya City Univ, West Med Ctr, Nagoya, Aichi, Japan
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE361
引用
收藏
页码：S406 / S406
页数：1
相关论文
共 50 条
  • [11] Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma
    Oshiro, Yoshiko
    Mizumoto, Masashi
    Okumura, Toshiyuki
    Fukuda, Kuniaki
    Fukumitsu, Nobuyoshi
    Abei, Masato
    Ishikawa, Hitoshi
    Takizawa, Daichi
    Sakurai, Hideyuki
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 (02) : 240 - 245
  • [12] Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan
    Nishie, Akihiro
    Goshima, Satoshi
    Haradome, Hiroki
    Hatano, Etsuro
    Imai, Yasuharu
    Kudo, Masatoshi
    Matsuda, Masanori
    Motosugi, Utaroh
    Saitoh, Satoshi
    Yoshimitsu, Kengo
    Crawford, Bruce
    Kruger, Eliza
    Ball, Graeme
    Honda, Hiroshi
    CLINICAL THERAPEUTICS, 2017, 39 (04) : 738 - 750
  • [13] Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan
    Masahiro Kobayashi
    Masatoshi Kudo
    Namiki Izumi
    Shuichi Kaneko
    Mie Azuma
    Ronda Copher
    Genevieve Meier
    Janice Pan
    Mika Ishii
    Shunya Ikeda
    Journal of Gastroenterology, 2019, 54 : 558 - 570
  • [14] Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan
    Kobayashi, Masahiro
    Kudo, Masatoshi
    Izumi, Namiki
    Kaneko, Shuichi
    Azuma, Mie
    Copher, Ronda
    Meier, Genevieve
    Pan, Janice
    Ishii, Mika
    Ikeda, Shunya
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 558 - 570
  • [15] Preliminary results of hypofractionated proton beam therapy for hepatocellular carcinoma
    Fukumitsu, N.
    Tokuuye, K.
    Hashimoto, T.
    Sugahara, S.
    Kagei, K.
    Hata, M.
    Ohara, K.
    Akine, Y.
    EJC SUPPLEMENTS, 2005, 3 (02): : 206 - 206
  • [16] Pembrolizumab as second-line therapy of hepatocellular carcinoma: A cost-effectiveness analysis
    Chan, S.
    Chiang, C.
    Lee, S.
    Wong, I.
    Choi, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S174 - S174
  • [17] Preliminary results of hypofractionated proton beam therapy for hepatocellular carcinoma
    Fukumitsu, N.
    Tokuuye, K.
    Hashimoto, T.
    Sugahara, S.
    Hata, M.
    Ohara, K.
    Tohno, E.
    Akine, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S279 - S280
  • [18] EVALUATING THE COST-EFFECTIVENESS RESULTS OF DIAGNOSTIC STRATEGIES FOR HEPATOCELLULAR CARCINOMA IN JAPAN
    Uchida-Nakakoji, M.
    Nishie, A.
    Ball, G.
    Kruger, E.
    Crawford, B.
    Honda, H.
    VALUE IN HEALTH, 2017, 20 (05) : A245 - A245
  • [19] A Literature Survey on Cost-Effectiveness of Proton Beam Therapy in the Management of Breast Cancer Patients
    Reiazi, Reza
    Norozi, Amir
    Etedadialiabadi, Maryam
    IRANIAN JOURNAL OF CANCER PREVENTION, 2015, 8 (06)
  • [20] Cost-effectiveness analysis of cochlear dose reduction by proton beam therapy for medulloblastoma in childhood
    Hirano, Emi
    Fuji, Hiroshi
    Onoe, Tsuyoshi
    Kumar, Vinay
    Shirato, Hiroki
    Kawabuchi, Koichi
    JOURNAL OF RADIATION RESEARCH, 2014, 55 (02) : 320 - 327
12345